What treatment approach to intrapartum maternal fever has the best fetal outcomes? by Snyder, Matthew et al.
	 vol	56,	No	5	/	may	2007	 401www.jfponline.com
CliniCal INquIrIes From the Family Physicians 
Inquiries Network
  
What treatment approach  
to intrapartum maternal fever  
has the best fetal outcomes?
Evidence-based answer
a	combination	of	beta-lactam	and	
aminoglycoside	antibiotics	are	the	
recommended	empiric	agents	for	the	
treatment	of	acute	chorioamnionitis,	
given	that	no	head-to-head	trials	exist	
(strength	of	recommendation	[sor]:	C,	
based	on	expert	opinion).	Intrapartum	
antibiotic	treatment	is	not	superior	to	
postpartum	antibiotics	for	reducing	
neonatal	sepsis	and	pneumonia	(sor:	C,	
based	on	patient-oriented,	underpowered	
randomized	trials).	
Clinical commentary
Carefully follow laboring patients with 
fever for other signs of chorioamnionitis
The	data	on	the	best	antibiotic	treatment	
of	clinical	chorioamnionitis	remains	as	
slim	as	ever,	it	appears.	But	since	experts	
continue	to	recommend	potentially	toxic	
gentamicin	as	part	of	therapy,	you	should	
carefully	monitor	laboring	patients	at	term	
who	develop	a	fever	for	the	development	of	
other	diagnostic	signs	of	chorioamnionitis.	
While	maternal	and	fetal	tachycardia	are	
frequently	caused	by	conditions	other	
than	infection,	their	appearance	in	a	febrile	
gravida	should	prompt	full	chorioamnionitis	
therapy	(even	in	patients	already	on	empiric	
antibiotics	for	group	B	streptococci).	With	
epidural	anesthesia,	uterine	tenderness	
is	an	unreliable	sign	of	infection.	Purulent	
amniotic	fluid	is	a	late	sign	and	rarely	
contributes	clinically.
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z Evidence summary
Acute chorioamnionitis (or intra- 
amniotic infection) poses a high risk of 
maternal and neonatal morbidity. Neo-
natal sepsis or pneumonia occurs in up 
to 24% of infants born to mothers with 
chorioamnionitis;1 1% to 2% of preg-
nancies complicated by chorioamnion-
itis end in neonatal death.1,2 
Acute chorioamnionitis is defined as 
intrapartum maternal fever and maternal 
tachycardia, fetal tachycardia, uterine 
tenderness, or purulent amniotic fluid.1,3 
Antibiotic treatment of acute chorioamni-
onitis is widely accepted, yet in vivo stud-
ies to determine the most effective empiric 
antibiotic regimens are lacking.
Intrapartum antibiotics  
probably reduce sepsis
Although few well-designed trials stand 
out, a Cochrane review4 summarizing 
2 relevant studies is available. Gibbs et al3 
performed an underpowered, randomized 
comparative trial of intrapartum vs post-
partum treatment of chorioamnionitis, 
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with both groups (45 patients total) receiv-
ing ampicillin 2 g IV every 6 hours plus 
gentamicin 1.5 mg/kg IV every 8 hours.3 
Those women who underwent cesarean 
section also received clindamycin 900 mg 
IV every 8 hours starting at cord clamp-
ing. In this study, investigators reported 
neonatal sepsis was significantly reduced 
with intrapartum treatment (0 vs 21%; 
P=.03, number needed to treat=4.8), as 
were neonatal hospital stays (3.8 vs 5.7 
days; P=.02), regardless of delivery meth-
od. The study had been planned for 92 
patients; it was stopped early (n=48) after 
an interim analysis.
Because of the small sample size, oth-
er findings from the study must be viewed 
with caution. Intrapartum treatment with 
antibiotics was associated with a “signifi-
cant” clinical reduction in neonatal sepsis 
(relative risk [RR]=0.08; 95% confidence 
interval [CI], 0.00–1.44) and pneumonia 
(RR=0.15; 95% CI, 0.01–2.92) compared 
with treatment given immediately post-
partum; however, neither value was truly 
statistically significant according to the 
Cochrane review.4 
The research suggests a potential ben-
efit to adding clindamycin to ampicillin 
and gentamicin. In an effort to test this, 
1 study randomized 133 women into 
2 arms—treatment with ampicillin, gen-
tamicin, and clindamycin compared with 
ampicillin and gentamicin alone—and 
found no additional benefit in regards to 
neonatal sepsis (RR=2.16; 95% CI, 0.20–
23.21) or neonatal death (RR=0.72; 95% 
CI, 0.12–4.16).1 There was a trend towards 
a decrease in the incidence of postpartum 
endometritis in women who received am-
picillin, gentamicin, and clindamycin, but 
this did not reach statistical significance 
(RR=0.54; 95% CI, 0.19–1.49).4
Recommendations from others 
A 2002 bulletin from American College of 
Obstetricians and Gynecologists (ACOG) 
and the American Academy of Pediatrics5 
recommended the combination of ampicil-
lin 2 gm IV every 4 to 6 hours or penicillin 
5 million units IV every 4 to 6 hours, plus 
an aminoglycoside (such as gentamicin 1.5 
mg/kg IV every 8 hours), since this regimen 
provides appropriate coverage for typical 
organisms associated with acute chorio-
amnionitis. At the time the bulletin was 
published, the use of single daily dosing 
of aminoglycoside did not have sufficient 
studies to back its use. In addition, ACOG 
recommends adding clindamycin, metro-
nidazole, or an extended-spectrum third-
generation cephalosporin to the treatment 
regimen if cesarean section is required, to 
provide coverage for anaerobic organ-
isms. They recommend clindamycin 900 
mg IV every 8 hours to replace amoxicil-
lin in penicillin-allergic patients. The Not-
tingham Guideline Development Group 
recommends amoxicillin 2 gm IV initially 
then 1 gm every 8 hours,  and in place of 
gentamicin, recommends metronidazole 
500 mg IV, every 8 hours (or 1 gm PR 
twice a day).6 Both recommendations sug-
gest clindamycin 900 mg IV every 8 hours 
to replace amoxicillin in penicillin-allergic 
patients. For patients with nonanaphylac-
tic reactions to penicillin, they recommend 
cefotaxime 1 g IV every 8 hours.  n
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